                         SEQUENCE LISTING

<110>  BRAHMS Aktiengesellschaft
 
<120>  Verfahren zur Detektion von Analyten

<130>  N1918 PCT BLN

<150>  DE 10 2007 029 766.3
<151>  2007-06-22

<150>  DE 10 2007 037 068.9
<151>  2007-08-04

<160>  11    

<170>  PatentIn version 3.4

<210>  1
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<221>  source
<223>  /note="Description of artificial sequence: His-tag peptide PRG12"

<400>  1

Arg Gly Ser His His His His His His Gly Gly Cys 
1               5                   10          


<210>  2
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<221>  source
<223>  /note="Description of artificial sequence: Oligo-Asp peptide 
       D14C"

<400>  2

Asp Asp Asp Asp Asp Asp Asp Asp Asp Asp Asp Asp Asp Asp Cys 
1               5                   10                  15  


<210>  3
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<221>  source
<223>  /note="Description of artificial sequence: Flag-tag peptide 
       PDC12"

<400>  3

Asp Tyr Lys Asp Asp Asp Asp Lys Gly Gly Gly Cys 
1               5                   10          


<210>  4
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<221>  source
<223>  /note="Description of artificial sequence: ProtC-tag peptide 
       PEG15"

<400>  4

Glu Asp Gln Val Asp Pro Arg Leu Ile Asp Gly Lys Gly Gly Cys 
1               5                   10                  15  


<210>  5
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<221>  source
<223>  /note="Description of artificial sequence: Oligo-Lys peptide 
       K14C"

<400>  5

Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Cys 
1               5                   10                  15  


<210>  6
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<221>  source
<223>  /note="Description of artificial sequence: PPL41 peptide"

<400>  6

Pro Glu Val Pro Pro Trp Thr Gly Glu Val Ser Pro Ala Gln Arg Asp 
1               5                   10                  15      


Gly Gly Ala Leu Gly Gly Gly Gly Arg Gly Pro Trp Asp Ser Ser Asp 
            20                  25                  30          


Arg Ser Ala Leu Leu Lys Ser Lys Leu 
        35                  40      


<210>  7
<211>  44
<212>  PRT
<213>  Artificial Sequence

<220>
<221>  source
<223>  /note="Description of artificial sequence: PSW44 peptide"

<400>  7

Ser Ser Glu Glu His Leu Arg Gln Thr Arg Ser Glu Thr Met Arg Asn 
1               5                   10                  15      


Ser Val Lys Ser Ser Phe His Asp Pro Lys Leu Lys Gly Lys Pro Ser 
            20                  25                  30          


Arg Glu Arg Tyr Val Thr His Asn Arg Ala His Trp 
        35                  40                  


<210>  8
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<221>  source
<223>  /note="Description of artificial sequence: PAY33 peptide"

<400>  8

Ala Thr Gln Leu Asp Gly Pro Ala Gly Ala Leu Leu Leu Arg Leu Val 
1               5                   10                  15      


Gln Leu Ala Gly Ala Pro Glu Pro Phe Glu Pro Ala Gln Pro Asp Ala 
            20                  25                  30          


Tyr 
    


<210>  9
<211>  48
<212>  PRT
<213>  Artificial

<220>
<221>  source
<223>  /note="Description of artificial sequence: peptide 45-92"

<400>  9

Glu Leu Arg Met Ser Ser Ser Tyr Pro Thr Gly Leu Ala Asp Val Lys 
1               5                   10                  15      


Ala Gly Pro Ala Gln Thr Leu Ile Arg Pro Gln Asp Met Lys Gly Ala 
            20                  25                  30          


Ser Arg Ser Pro Glu Asp Ser Ser Pro Asp Ala Ala Arg Ile Arg Val 
        35                  40                  45              


<210>  10
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<221>  source
<223>  /note="Description of artificial sequence: SPCD19 peptide"

<400>  10

Cys Arg Pro Gln Asp Met Lys Gly Ala Ser Arg Ser Pro Glu Asp Ser 
1               5                   10                  15      


Ser Pro Asp 
            


<210>  11
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<221>  source
<223>  /note="Description of artificial sequence: PSV11 peptide"

<400>  11

Cys Ser Ser Pro Asp Ala Ala Arg Ile Arg Val 
1               5                   10      


